Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Avanos Medical (AVNS) Interest Expenses (2016 - 2025)

Avanos Medical's Interest Expenses history spans 11 years, with the latest figure at $3.2 million for Q3 2024.

  • For Q3 2024, Interest Expenses fell 31.91% year-over-year to $3.2 million; the TTM value through Dec 2024 reached $9.4 million, down 37.33%, while the annual FY2023 figure was $15.0 million, 50.0% up from the prior year.
  • Interest Expenses for Q3 2024 was $3.2 million at Avanos Medical, up from $3.1 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $4.7 million in Q3 2023 and bottomed at $700000.0 in Q4 2021.
  • The 5-year median for Interest Expenses is $3.1 million (2024), against an average of $2.8 million.
  • The largest annual shift saw Interest Expenses tumbled 81.4% in 2021 before it skyrocketed 328.57% in 2022.
  • A 5-year view of Interest Expenses shows it stood at $2.7 million in 2020, then plummeted by 74.07% to $700000.0 in 2021, then surged by 328.57% to $3.0 million in 2022, then increased by 10.0% to $3.3 million in 2023, then decreased by 3.03% to $3.2 million in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Interest Expenses are $3.2 million (Q3 2024), $3.1 million (Q2 2024), and $3.1 million (Q1 2024).